Cypre Inc. is a biotechnology company developing novel 3D in vitro models of the tumor microenvironment (TME) for cancer drug discovery. The company employs proprietary high content imaging algorithms and in-house built 3D hydrogel technology to map efficacy and novel insights to therapeutic mechanisms across all modalities - small molecules,